Trending Biotech Companies
Top gainers and losers in biotech, ranked by market cap performance. Filter by 24-hour, 7-day, or 30-day changes.
Gainers127
Losers60
Best performer+27.83%
| # | Company | Country | 7D Change | Market Cap |
|---|---|---|---|---|
| 1 |  FortreaFTRE | United States | +27.83% | $1.4B |
| 2 |  TG TherapeuticsTGTX | United States | +27.10% | $6.7B |
| 3 |  Viridian TherapeuticsVRDN | United States | +26.68% | $1.7B |
| 4 |  HumacyteHUMA | United States | +26.32% | $229.8M |
| 5 |  uniQureQURE | Netherlands | +26.24% | $1.5B |
| 6 |  InflaRxIFRX | Germany | +26.19% | $187.2M |
| 7 |  Kolon TissueGene950160.KQ | United States | +25.29% | $7.3B |
| 8 |  MannKindMNKD | United States | +25.00% | $1.1B |
| 9 |  Inovio PharmaceuticalsINO | United States | +24.55% | $113.8M |
| 10 |  Integra LifeSciencesIART | United States | +23.84% | $1.1B |
| 11 |  CryoPort SystemsCYRX | United States | +23.29% | $638.1M |
| 12 |  VeracyteVCYT | United States | +23.18% | $3.1B |
| 13 |  Nxera Pharma4565.T | Japan | +22.58% | $683.9M |
| 14 |  NewAmsterdam PharmaNAMS | Netherlands | +22.58% | $4.7B |
| 15 |  ImmunicIMUX | United States | +21.76% | $156.3M |
| 16 |  NanobiotixNBTX | France | +21.33% | $2.0B |
| 17 |  Assertio HoldingsASRT | United States | +21.12% | $144.8M |
| 18 |  Legend BiotechLEGN | United States | +21.11% | $5.2B |
| 19 |  Nuvectis PharmaNVCT | United States | +20.84% | $273.5M |
| 20 |  Candel TherapeuticsCADL | United States | +20.40% | $584.0M |
| 21 |  Tenaya TherapeuticsTNYA | United States | +20.11% | $184.8M |
| 22 |  EvolusEOLS | United States | +19.89% | $420.8M |
| 23 |  BillionToOneBLLN | United States | +19.89% | $4.0B |
| 24 |  Indoco RemediesINDOCO.NS | India | +19.65% | $222.4M |
| 25 |  Biomea FusionBMEA | United States | +18.98% | $118.6M |
| 26 |  Sight SciencesSGHT | United States | +18.88% | $298.7M |
| 27 |  BrukerBRKR | United States | +18.86% | $6.5B |
| 28 |  Insight Molecular DiagnosticsIMDX | United States | +18.66% | $153.0M |
| 29 |  SAB BiotherapeuticsSABS | United States | +17.87% | $269.2M |
| 30 |  Rapport TherapeuticsRAPP | United States | +17.82% | $1.9B |
| 31 |  Alpha TeknovaTKNO | United States | +17.65% | $201.6M |
| 32 |  Rhythm PharmaceuticalsRYTM | United States | +17.63% | $6.5B |
| 33 |  Cue BiopharmaCUE | United States | +17.46% | $113.0M |
| 34 |  WockhardtWOCKPHARMA.BO | United Kingdom | +17.36% | $2.8B |
| 35 |  CytokineticsCYTK | United States | +17.27% | $9.5B |
| 36 |  Monopar TherapeuticsMNPR | United States | +17.24% | $421.9M |
| 37 |  BachemBANB.SW | Switzerland | +17.10% | $7.8B |
| 38 |  Aura BiosciencesAURA | United States | +16.98% | $909.4M |
| 39 |  NeurogeneNGNE | United States | +16.42% | $470.0M |
| 40 |  GRAILGRAL | United States | +16.39% | $2.6B |
| 41 |  MEDARTISMED | Switzerland | +16.32% | $138.6M |
| 42 |  ViatrisVTRS | United States | +15.62% | $20.1B |
| 43 |  UroGen PharmaURGN | United States | +15.61% | $1.4B |
| 44 |  MaaT PharmaMAAT.PA | France | +15.04% | $145.4M |
| 45 |  REGENXBIORGNX | United States | +14.25% | $542.5M |
| 46 |  OticonDEMANT.CO | Denmark | +13.88% | $7.7B |
| 47 |  Piramal PharmaPPLPHARMA.NS | India | +13.50% | $2.5B |
| 48 |  NeuroPaceNPCE | United States | +13.01% | $646.2M |
| 49 |  Genscript Biotech1548.HK | China | +12.83% | $4.2B |
| 50 |  Tiziana Life SciencesTLSA | United Kingdom | +12.69% | $188.3M |